Informa Markets and Thailand's Health Ministry Join Forces To Deliver a Successful Edition of International Healthcare Week 2026 in Bangkok

by | PRNewswire Asia

BANGKOK, June 16, 2026 /PRNewswire/ — Informa Markets joins forces with Thailand’s Department of Health Service Support (DHSS) to unveil International Healthcare Week 2026, a transformative regional healthcare platform that will elevate...

Tiger Beer Proves Its Global Credentials in Bold Blind Tasting Experiment

by | PRNewswire Asia

77% of participants rated Tiger Beer as "excellent" or "very good" before knowing it was Tiger, reinforcing the beer’s world-class quality on taste alone. SINGAPORE, June 16, 2026 /PRNewswire/ — Tiger Beer invited Singaporeans to a...

Rediscover the Art of Gathering with the Luxury Group by Marriott International

by | PRNewswire Asia

The third edition of the Luxury Dining Series celebrates the joy of connection through shared dining and beverage experiences SINGAPORE, June 16, 2026 /PRNewswire/ — The Luxury Group by Marriott International is launching the third edition of its Luxury Dining...

From Turbine Supply to Ecosystem Building: Goldwind Outlines APAC Strategy at the APAC Wind Energy Summit

by | PRNewswire Asia

HANOI, Vietnam, June 16, 2026 /PRNewswire/ — Speaking at the GWEC APAC Wind Energy Summit in Hanoi, Goldwind, a reliable global strategic partner in clean energy, reaffirmed its deep commitment to the Asia-Pacific region. Operating in 10 countries across...

Six Regional Organisations Sign MoU to Strengthen Asia's Dengue Response as Cases Rise

by | PRNewswire Asia

Announced at the 9th Asia Dengue Summit in conjunction with ASEAN Dengue Day and the first WHO-recognised World Dengue Day, the MoU establishes a regional framework for knowledge-sharing, advocacy and coordinated dengue action. SINGAPORE, June 15, 2026 /PRNewswire/...

Akeso's Next-Generation HER3 ADC AK138D1 Combined with Ivonescimab: First Patient Enrolled in Phase Ib/II Breast Cancer Study, Advancing the IO2.0 + ADC2.0 Strategy

by | PRNewswire Asia

HONG KONG, June 15, 2026 /PRNewswire/ — Akeso, Inc. (HKEX: 9926) today announced that the first patient has been enrolled in the Phase Ib/II clinical study (AK138D1-202) evaluating its internally developed next-generation HER3 antibody-drug conjugate (ADC),...